로딩 중…
StockDiggingStockDigging

Abbott Laboratories

ABT· NYSE
$107.15+1.37%
2026-08-03

Financials

Valuation Metrics

Abbott Laboratories's Market Cap is $186.64B. At end of 2025 it was $217.77B. Ranked #79 of 3,112 in US market (top 3%), #49 of 1,667 on NYSE (top 3%), #3 of 206 in Health Care Equipment & Services (top 1%) by Market Cap.

Investment Metrics(as of 2026-08-03)

MetricValue
Size
Market Cap$186.64B
Revenue$46.59B
Net Income$5.42B
Total Assets$109.22B
Net Assets$51.11B
Employees115,000
Value
P/E34.40x
P/B3.65x
P/S4.01x
EV/EBITDA21.54x
FCF Yield4.67%
Profitability
ROE10.61%
ROA4.97%
Op. Margin17.03%
Revenue Growth13.02%
Earnings Growth-47.84%
Financial Health
Debt Ratio112.41%
Total Debt$32.61B
FCF$8.72B
Cash$5.10B
Current Ratio1.38x
Net Debt/EBITDA2.77x
Dividend
Div. Yield2.28%
Div. Growth6.36%
Performance
1Y Return-15.02%
1M Return12.32%
From 52W High-21.32%
1Y MDD-39.37%
Trading
Volume4,766,729 shares
Trading Value$513M
Per Share
EPS$3.73
BPS$29.84

Company Info

CEO Mr. Robert B. Ford
Employees 115,000
HQ Abbott Park, United States

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.